<i>P</i>_<i>21</i> fracture intensity with increasing distance from the crater centre for the sandstone (a) and limestone (b) target blocks. by Oliver Campbell (17283127)

Decreased MBP levels in <i>Large</i>^{<i>myd/myd</i>} and <i>POMGnT1</i>-KO mice at the RC and OSL. by Shigefumi Morioka (8893511)

Fig 7 - by Vu Phong Lam (19225959)

Subjects:

Geographical distribution of large cities and small cities. by Saul Estrin (8629173)

“…The Figure reveals two patterns: 1) the maximum level of innovation is higher in large cities (2.53) than in small cities (2.02); 2) among large cities in <b>a</b>, innovation levels in general decrease with nightlight density. …”

Visualization of the impact of group, choroidal thickness (CT) and central choroidal thickness (cCT) on the visibility of large choroidal vessels (LCV). by Valentin Hacker (9956024)

NSC population and proliferation decrease drastically during the second postnatal week of DG development. by Cristina Medina-Menéndez (21800157)

Transformations of impulse responses by depolarization in <i>P</i>. <i>americana</i> model. by Roman V. Frolov (9647905)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Modeling electrical properties of the light-insensitive membrane of <i>P</i>. <i>americana</i>. by Roman V. Frolov (9647905)

Percentage of exhale flux penetrating through the mask fabric for different values of <i>c</i>_<i>k</i>; a–c and d–f decreasing porosity for outward and inward protection model respectively; <i>k</i>_<i>L</i> is head loss coefficient for inward protection model. by Akshay Anand (118579)

DataSheet_1_Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma.docx by Simon Le Gallou (10742601)

“…<p>Absolute count of circulating monocytes has been proposed as an independent prognostic factor in diffuse large B-cell lymphoma (DLBCL). However, monocyte nomenclature includes various subsets with pro-, anti-inflammatory, or suppressive functions, and their clinical relevance in DLBCL has been poorly explored. …”

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Subjects:

Snail infection prevalence in 0.38 ppt, 1.9 ppt, 3.8 ppt, and 5.7 ppt salinity treatments after exposure to <i>Schistosoma mansoni</i> miracidia. by Ao Yu (1348512)

Decreased recovery times were observed after repeated handling and anesthesia sessions. by Lingzhi Wang (114519)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Subjects:

Pseudocode of the simulation program (see Supplementary Materials for <i>R</i> codes S1 File). by Farrokh Habibzadeh (12256529)

Prognostic value of lactate dehydrogenase, serum albumin and the lactate dehydrogenase/albumin ratio in patients with diffuse large B-cell lymphoma by Wenke Wu (17665962)

“…<p>To investigate the prognostic value of lactate dehydrogenase (LDH), serum albumin (ALB) and the lactate dehydrogenase/albumin ratio (LAR) in diffuse large B-cell lymphoma (DLBCL) before primary treatment.…”